SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (14642)9/16/2000 8:55:41 PM
From: Robert K.  Read Replies (1) of 17367
 
simple example: If drug A is able to disolve clots and disolving clots is clearly good to save a limb, then one could MAYBE considered just disolving the clots as a basis for approval... of drug A
>
simple example: If drug bpi is able to disolve clots and disolving clots is clearly good to save a limb, then one could MAYBE considered just disolving the clots as a basis for approval... of drug A (I believe bpi disoles clots)
>
simple example: If drug bpi is able to neutralize endotoxins and neutralizing endotoxins is clearly good to save a limb or a life, then one could MAYBE considered just neutralizing endotoxins as a basis for approval... of drug BPI (make sense to me, thanks Cacaito)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News